补充性干预的可行性 致使人衰弱的症状综合体归因于 (FIND):为随机的,等候名单控制的可行性试验的研究协议
Richard A A Kanaan1, Richard Macdonell2, Michelle Long3
1Department of Psychiatry, University of Melbourne, Heidelberg, Victoria, Australia richard.kanaan@unimelb.edu.au.
BMJ open
|March 10, 2026
概括
这项研究调查了接受和承诺疗法 (ACT) 对澳大利亚 (DSCATT) 致使人衰弱的症状复合物的可行性. 试点试验将评估ACT作为这种无法解释的慢性疾病的补充治疗的可接受性和有效性.
科学领域:
- 心理学 心理学 心理学
- 临床医学 临床医学
- 公共卫生 公共卫生
背景情况:
- 致使人衰弱的症状综合体归因于 (DSCATT) 是澳大利亚的一种无法解释的慢性疾病,其特点是致使人衰弱的症状归因于咬.
- 目前,DSCATT没有特定的原因或公认的治疗方法,尽管它对患者的生活产生了重大影响.
- 心理疗法,如接受和承诺疗法 (ACT),在治疗其他不明原因综合征的症状和改善生活质量方面表现有前途.
研究的目的:
- 评估对DSCATT患者进行ACT知情干预的可行性.
- 评估这种辅助疗法的可接受性,实用性和需求.
- 检查干预对健康,福祉,安全,潜在调解员和初步成本效益的影响.
主要方法:
- 一个为期32周的,随机的,等候名单控制的,并行融合的混合方法试点试验.
- 参与者 (1:1比率) 将接受16次ACT知情治疗或被分配到等候名单对照组.
- 将收集定量和定性数据,以参与者保留率作为首要可行性结果.
主要成果:
- 本节不适用,因为摘要描述的是研究方案,而不是结果.
- 本节不适用,因为摘要描述的是研究方案,而不是结果.
- 本节不适用,因为摘要描述的是研究方案,而不是结果.
结论:
- 本研究协议概述了一项试点试验,以确定ACT对DSCATT的可行性.
- 结果将告知ACT作为辅助治疗的潜力,以改善这种使人衰弱的疾病患者的结果.
- 该试验已注册 (ACTRN12623000372684) 并获得了伦理审批.
相关概念视频
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
What is an Experiment?
12.3K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
12.3K
Randomized Experiments
6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Cochran's Q Test
1.2K
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
1.2K
Censoring Survival Data
689
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
689


